Neoplasms, Unknown Primary
"Neoplasms, Unknown Primary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metastases in which the tissue of origin is unknown.
Neoplasms, Unknown Primary
- Neoplasms, Unknown Primary
- Occult Primary Neoplasms
- Neoplasms, Occult Primary
- Neoplasm, Occult Primary
- Occult Primary Neoplasm
- Primary Neoplasm, Occult
- Primary Neoplasms, Occult
- Unknown Primary Neoplasms
- Neoplasm, Unknown Primary
- Primary Neoplasm, Unknown
- Primary Neoplasms, Unknown
- Unknown Primary Neoplasm
Unknown Primary Tumors
- Unknown Primary Tumors
- Primary Tumor, Unknown
- Primary Tumors, Unknown
- Tumor, Unknown Primary
- Tumors, Unknown Primary
- Unknown Primary Tumor
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Unknown Primary".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Unknown Primary".
This graph shows the total number of publications written about "Neoplasms, Unknown Primary" by people in Harvard Catalyst Profiles by year, and whether "Neoplasms, Unknown Primary" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Neoplasms, Unknown Primary" by people in Profiles.
Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary. Am J Surg Pathol. 2023 04 01; 47(4):440-452.
Developmental Deconvolution for Classification of Cancer Origin. Cancer Discov. 2022 11 02; 12(11):2566-2585.
Diagnostic error, interlaboratory communication, and resource management in cytopathology-surgical pathology collaboration: A 58-year-old woman with metastatic disease of unknown primary. Cancer Cytopathol. 2023 02; 131(2):75-77.
Unusual presentation of HPV-positive squamous cell carcinoma of the nasolacrimal duct as carcinoma of unknown primary. Am J Otolaryngol. 2022 May-Jun; 43(3):103457.
Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary. J Immunother Cancer. 2022 01; 10(1).
AI-based pathology predicts origins for cancers of unknown primary. Nature. 2021 06; 594(7861):106-110.
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas. Clin Cancer Res. 2021 04 15; 27(8):2226-2235.
A case of metastatic adenocarcinoma of unknown primary in a pediatric patient: Opportunities for precision medicine. Pediatr Blood Cancer. 2021 04; 68(4):e28780.
Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling. Ann Surg Oncol. 2020 Dec; 27(13):5240-5247.
Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume. Eur Arch Otorhinolaryngol. 2020 Jun; 277(6):1753-1761.